Collegium Pharmaceutical (COLL) Tax Provisions (2020 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Tax Provisions of $4.2 million for Q1 2026, up 501.99% year-over-year from $705000.0 in Q1 2025, and down 64.85% quarter-over-quarter from $12.1 million in Q4 2025.
Collegium Pharmaceutical (COLL) Tax Provisions (2020 - 2026) Analysis & Trends
Collegium Pharmaceutical's Tax Provisions history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 501.99% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $33.3 million (up 57.21% YoY), while the FY2025 annual figure was $29.7 million, up 1.26% from the prior year.
- Tax Provisions for Q1 2026 stood at $4.2 million, down from $12.1 million in the prior quarter.
- The five-year high for Tax Provisions was $14.8 million in Q4 2023, with the low at -$2.8 million in Q1 2022.
- The 5-year median for Tax Provisions is $4.8 million (2023), against an average of $5.1 million.
- The sharpest annual moves came in 2022 and 2024: Tax Provisions sank 1375.0% in 2022, then surged 6900.76% in 2024.
- Collegium Pharmaceutical's Tax Provisions stood at -$592000.0 in 2022, then jumped by 2594.93% to $14.8 million in 2023, then slumped by 67.96% to $4.7 million in 2024, then surged by 155.08% to $12.1 million in 2025, then slumped by 64.85% to $4.2 million in 2026.
- Business Quant data shows COLL's Tax Provisions at $4.2 million in Q1 2026, $12.1 million in Q4 2025, and $11.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Collegium Pharmaceutical | 892.02 Mn | 742.71 Mn | 110.29 Mn | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 4.24 Mn |
| Dec 31, 2025 | 12.07 Mn |
| Sep 30, 2025 | 11.93 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 705,000.00 |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Mar 31, 2024 | 8.91 Mn |
| Dec 31, 2023 | 14.77 Mn |
| Sep 30, 2023 | 8.15 Mn |
| Jun 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | -131,000.00 |
| Dec 31, 2022 | -592,000.00 |
| Sep 30, 2022 | 975,000.00 |
| Jun 30, 2022 | -1.46 Mn |
| Mar 31, 2022 | -2.77 Mn |
| Dec 31, 2021 | -13.84 Mn |
| Sep 30, 2021 | 991,000.00 |